Phase 2 Men Clinical Trials
516 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 516 trials
Recruiting
Phase 2
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
Focal Segmental Glomerulosclerosis
National Human Genome Research Institute (NHGRI)30 enrolled1 locationNCT06664814
Recruiting
Phase 2
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
Hip arthroscopyTotal Hip Arthroplasty (THA)Total Knee Arthroplasty+1 more
Rush University Medical Center240 enrolled1 locationNCT07020312
Recruiting
Phase 2
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled28 locationsNCT06627179
Recruiting
Phase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Functional Hypothalamic Amenorrhea (FHA)
Regeneron Pharmaceuticals34 enrolled8 locationsNCT07235917
Recruiting
Phase 2
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+12 more
National Cancer Institute (NCI)120 enrolled84 locationsNCT06649812
Recruiting
Phase 2
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
ASCVDVascular InflammationASCVD Management
Massachusetts General Hospital120 enrolled1 locationNCT06691217
Recruiting
Phase 2
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Retinitis Pigmentosa
Kiora Pharmaceuticals, Inc.36 enrolled5 locationsNCT06628947
Recruiting
Phase 2Phase 3
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Kaposiform Hemangioendothelioma (KHE)Kasabach Merritt Phenomenon
Yi Ji76 enrolled1 locationNCT07656909
Recruiting
Phase 2
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more
University of Washington22 enrolled2 locationsNCT06518057
Recruiting
Phase 2
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
Sleep DisturbanceAMCI - Amnestic Mild Cognitive Impairment
Johns Hopkins University100 enrolled1 locationNCT05282550
Recruiting
Phase 1Phase 2
Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Retinitis Pigmentosa
Chigenovo Co., Ltd18 enrolled1 locationNCT06952842
Recruiting
Phase 2
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting
Phase 2
Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias
Older Adults With Elevated Dementia Risk
University of South Carolina54 enrolled1 locationNCT07638046
Recruiting
Phase 2
Chinese Adults With Kidney Disease
Immunoglobulin A Nephropathy (IgAN)IC-MPGNComplement 3 Glomerulopathy (C3G)
ADARx Pharmaceuticals, Inc.30 enrolled10 locationsNCT07522099
Recruiting
Phase 2
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
IgA Nephropathy (IgAN)IgANC3G+2 more
ADARx Pharmaceuticals, Inc.45 enrolled29 locationsNCT06989359
Recruiting
Phase 2
177Lu-DOTATATE for Recurrent Meningioma
Recurrent Meningioma
European Organisation for Research and Treatment of Cancer - EORTC136 enrolled19 locationsNCT06326190
Recruiting
Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
Mild Cognitive Impairment
University of Colorado, Denver236 enrolled1 locationNCT05822362
Recruiting
Phase 2
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NonSegmental Vitiligo
Takeda200 enrolled70 locationsNCT07108283
Recruiting
Phase 1Phase 2
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
Alzheimer Dementia (AD)
The Methodist Hospital Research Institute30 enrolled1 locationNCT07651319
Recruiting
Phase 2Phase 3
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial
developmental delayGingivitisPeriodontitis+2 more
University of Washington6,000 enrolled1 locationNCT07424846